Aya Fukuma Ozaki
Assistant Professor of Clinical Pharmacy
School of Pharmacy & Pharmaceutical Sciences
School of Pharmacy & Pharmaceutical Sciences
B.S., School of Pharmaceutical Sciences, Toho University, Japan, Pharmacology
Pharm.D., College of Pharmacy, Western University of Health Sciences
Pharm.D., College of Pharmacy, Western University of Health Sciences
University of California, Irvine
Berk Hall, 106D
Mail Code: 3958
Irvine, CA 92697
Berk Hall, 106D
Mail Code: 3958
Irvine, CA 92697
Research Interests
Cardiovascular diseases, medication utilization, pharmacogenomics, health disparities, evidence-based medicine
Awards and Honors
2022 Best Poster Presentation Award
Asian Conference on Clinical Pharmacy
2020 Early Career Investigator Travel Grant
American Heart Association, Quality of Care and Outcomes Research Conference
2015 Summer Student Research Fellowship
Western University of Health Sciences
Asian Conference on Clinical Pharmacy
2020 Early Career Investigator Travel Grant
American Heart Association, Quality of Care and Outcomes Research Conference
2015 Summer Student Research Fellowship
Western University of Health Sciences
Publications
12 Urano K, Hatano N, Ozeki K, Komoda M, Kawahara M, Ozaki AF. How to promote practical EBM
education - The learning cycle in university and clinical practice. Japan Society of Pharmaceutical
Education. (Accepted)
Description: I contributed to designing the study, drafting and critical revision of the manuscript.
11 Ozaki AF, Jackevicius CA, Chong A, Sud M, Fang J, Austin PC, Ko DT. Hospital-level variation in
ticagrelor use in patients with acute coronary syndrome. J Am Heart Assoc. 2022;11(13):e024835.
Description: I led the research team, designed the study, drafted and finalized the manuscript.
10 Ozaki AF, Cadiz C, Hurley-Kim K, Wisseh C, Knox E, Lee JY, Wong A, Patel SG, Chan A.
worldwide characteristics and trends of pharmacist interventions contributed to minimize health
disparities. J Am Coll Clin Pharm. 2022;5(8):853-64
Description: As a primary and corresponding author, I led the team to develop the study, collect
and analyze data, and write the manuscript.
9 Hurley-Kim K, Unonu J, Wisseh C, Cadiz C, Knox E, Ozaki AF, Chan A. Health disparities in
pharmacy practice within the community: Let's brainstorm for solutions. Front Public Health.
2022;10:847696.
Description: I contributed to designing the study, drafting and critical revision of the manuscript.
8 Ozaki AF, Krumholz HM, Mody FV, et al. Prior authorization, copayments, and utilization of
sacubitril/valsartan in medicare and commercial plans in patients with heart failure with reduced
ejection fraction [published online ahead of print, 2021 Sep 1]. Circ Cardiovasc Qual Outcomes
2021;CIRCOUTCOMES120007665.
Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
7 Ozaki AF, Krumholz HM, Mody FV, Jackevicius CA. National trends in the use of
sacubitril/valsartan. J Card Fail 2021;27:839-47.
Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
6 Hamaguchi S, Kariya M, Ozaki AF, Namekata I, Tanaka H. Contribution of ATP-mediated positive
feedback to sympathetic nerve-induced positive inotropy in guinea pig ventricular myocardium. Biol
Pharm Bull 2021;44:458-60.
Description: I contributed to designing the study and critical revision of the manuscript
5 Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA. Real-world adherence and
persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and
meta-analysis. Circ Cardiovasc Qual Outcomes. 2020;13:e005969.
doi:10.1161/CIRCOUTCOMES.119.005969
Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
4 Jackevicius CA, Krumholz HM, Chong A, Koh M, Ozaki AF, Austin PC, Udell JA, Ko DT.
Population impact of generic valsartan recall. Circulation. 2020;141:411-3.
doi:10.1161/CIRCULATIONAHA.119.044494
Description: I contributed to designing the study, and critical revision of the manuscript.
3 Ny P, Ozaki AF, Pallares J, Nieberg P, Wong-Beringer A. Antimicrobial stewardship opportunities in
patients with bacteremia not identified by BioFire FilmArrary. J Clin Microbiol. 2019 Apr;57(5). Pii:
e01941-18. doi: 10.1128/JCM.01941-18
Description: I contributed to designing the study and analyzing data.
2 Ozaki AF, Jackevicius CA. Evidence-based practice review of the ASCEND Trial. J Contemp Pharm
Practice. 2019;66:48-52
Description: I designed the study, analyzed, drafted and revised the manuscript.
1 Ozaki AF, Nakagawa S, Jackevicius CA. Cross-cultural comparison of pharmacy students’ attitudes,
knowledge, practice, and barriers regarding evidence-based medicine. Am J Pharm Educ. 2017;
Published online ahead of print Dec 12, 2017. doi/pdf/10.5688/ajpe6710
Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
Other Experience
Fellow in Cardiovascular Outcomes Research
Western University of Health Sciences, Practice Site: Veterans Affair Greater Los Angeles 2018—2021
Western University of Health Sciences, Practice Site: Veterans Affair Greater Los Angeles 2018—2021
Link to this profile
https://faculty.uci.edu/profile/?facultyId=7151
https://faculty.uci.edu/profile/?facultyId=7151
Last updated
03/16/2023
03/16/2023